Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 12:31 AM
NCT ID:
NCT00490867
Eligibility Criteria:
Inclusion Criteria:
* Type II diabetics; diagnosed on a clinical basis: positive family history; age of manifestation \> 40 years; BMI \>25; initial therapy without insulin
* Age: 40 - 65 years
* Body mass index between 26 and 35 \[Wascher 1998\]
* Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
* Treatment with concomitent therapy, including vasoactive drugs, is allowed during the study. Will not be changed during the study
Exclusion Criteria:
* Participation in a clinical trial in the 3 weeks preceeding the study
* History or signs of macrovascular disease
* History of hypertensitivity to the trial drug or to drugs with a similar chemical structure
* Changes in concomitant therapy during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
65 Years
Study:
NCT00490867
Study Brief:
Protocol Section:
NCT00490867